HeimSBHMY • OTCMKTS
add
Sino Biopharmaceutical Unsponsored Caymand Islands ADR
Við síðustu lokun
20,16 $
Árabil
7,15 $ - 20,16 $
Markaðsvirði
161,91 ma. HKD
Meðalmagn
43,00
V/H-hlutf.
-
A/V-hlutfall
-
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (CNY) | jún. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 8,79 ma. | 10,71% |
Rekstrarkostnaður | 5,54 ma. | 15,96% |
Nettótekjur | 1,69 ma. | 12,31% |
Hagnaðarhlutfall | 19,28 | 1,42% |
Hagnaður á hvern hlut | — | — |
EBITDA | 1,98 ma. | 0,08% |
Virkt skatthlutfall | 16,45% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (CNY) | jún. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 19,82 ma. | 50,41% |
Heildareignir | 74,89 ma. | 12,28% |
Heildarskuldir | 29,12 ma. | 18,45% |
Eigið fé alls | 45,78 ma. | — |
Útistandandi hlutabréf | 18,00 ma. | — |
Eiginfjárgengi | 10,90 | — |
Arðsemi eigna | 5,69% | — |
Ávöxtun eigin fjár | 7,38% | — |
Peningaflæði
Breyting á handbæru fé
| (CNY) | jún. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 1,69 ma. | 12,31% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
Framkvæmdastjóri
Stofnsett
2000
Vefsvæði
Starfsfólk
23.056
